Does MACITENTAN Cause Product dose omission issue? 1,247 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,247 reports of Product dose omission issue have been filed in association with MACITENTAN (OPSYNVI). This represents 2.8% of all adverse event reports for MACITENTAN.
1,247
Reports of Product dose omission issue with MACITENTAN
2.8%
of all MACITENTAN reports
47
Deaths
434
Hospitalizations
How Dangerous Is Product dose omission issue From MACITENTAN?
Of the 1,247 reports, 47 (3.8%) resulted in death, 434 (34.8%) required hospitalization, and 12 (1.0%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MACITENTAN. However, 1,247 reports have been filed with the FAERS database.
What Other Side Effects Does MACITENTAN Cause?
Dyspnoea (8,315)
Death (5,864)
Headache (4,856)
Diarrhoea (3,669)
Pneumonia (3,531)
Nausea (3,463)
Hospitalisation (3,414)
Fatigue (3,172)
Fluid retention (2,861)
Dizziness (2,704)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which MACITENTAN Alternatives Have Lower Product dose omission issue Risk?
MACITENTAN vs MACITENTAN\TADALAFIL
MACITENTAN vs MAGNESIUM
MACITENTAN vs MAGNESIUM ASPARTATE
MACITENTAN vs MAGNESIUM ASPARTATE\POTASSIUM ASPARTATE
MACITENTAN vs MAGNESIUM HYDROXIDE